ES2131014A1 - Metodo para preparar sales mixtas de glucosamina. - Google Patents

Metodo para preparar sales mixtas de glucosamina.

Info

Publication number
ES2131014A1
ES2131014A1 ES09701784A ES9701784A ES2131014A1 ES 2131014 A1 ES2131014 A1 ES 2131014A1 ES 09701784 A ES09701784 A ES 09701784A ES 9701784 A ES9701784 A ES 9701784A ES 2131014 A1 ES2131014 A1 ES 2131014A1
Authority
ES
Spain
Prior art keywords
preparing mixed
glucosamine salts
crystalline form
metal selected
sulphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09701784A
Other languages
English (en)
Other versions
ES2131014B1 (es
Inventor
Maura De Wan
Guiseppe Volpi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rottapharm BV succursale di Lugano
Rottapharm BV
Original Assignee
Rotta Research Amsterdam Swiss Branch BV
Rotta Research BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Amsterdam Swiss Branch BV, Rotta Research BV filed Critical Rotta Research Amsterdam Swiss Branch BV
Publication of ES2131014A1 publication Critical patent/ES2131014A1/es
Application granted granted Critical
Publication of ES2131014B1 publication Critical patent/ES2131014B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Un método para preparar una forma cristalina terapéuticamente activa de sulfato de glucosamina que es estable a temperatura y humedad ambientes, y corresponde a la fórmula empírica (I), en la cual M representa un metal seleccionado entre el grupo que consiste en Na, K, Ca o Mg, x = 1 si y = 2, y x = 2 si y = 1, en la que se hacen reaccionar hidrocloruro de glucosamina y un sulfato de metal seleccionado entre Na, K, Ca y Mg en la relación estequiométrica definida por la fórmula (I), en un disolvente acuoso, y la forma cristalina estable es precipitada mediante la adición de un agente precipitante líquido miscible con agua.
ES009701784A 1996-08-19 1997-08-12 Metodo para preparar sales mixtas de glucosamina. Expired - Fee Related ES2131014B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH02024/96A CH690719A5 (it) 1996-08-19 1996-08-19 Procedimento per la preparazione di sali misti della glucosamina.

Publications (2)

Publication Number Publication Date
ES2131014A1 true ES2131014A1 (es) 1999-07-01
ES2131014B1 ES2131014B1 (es) 2000-02-01

Family

ID=4224138

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009701784A Expired - Fee Related ES2131014B1 (es) 1996-08-19 1997-08-12 Metodo para preparar sales mixtas de glucosamina.

Country Status (13)

Country Link
US (1) US5847107A (es)
JP (1) JP4177471B2 (es)
AT (1) AT408884B (es)
BE (1) BE1011326A5 (es)
CA (1) CA2212129C (es)
CH (1) CH690719A5 (es)
ES (1) ES2131014B1 (es)
FR (1) FR2752423B1 (es)
GB (1) GB2321056B (es)
GR (1) GR1003096B (es)
IE (1) IE970547A1 (es)
NL (1) NL1006790C2 (es)
PT (1) PT102043B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100381386B1 (ko) * 2000-07-28 2003-04-23 주식회사 효성 디-글루코사민의 제조 방법
BR0115801A (pt) * 2000-12-01 2005-12-13 Nicholas Piramal India Ltd Composto de sais metálicos de sulfato de glicosamina cristalinos, método e processo para a preparação do composto, e, composição farmacêutica
LT5148B (lt) 2000-12-01 2004-07-26 Nicholas Piramal India Limited Kristalinės gliukozamino sulfato metalų druskos ir jų gavimo būdas
ITMI20012818A1 (it) 2001-12-28 2003-06-28 Acraf Un metodo per preparare un composto della glucosammina e composto cosi ottenuto
JP2010059090A (ja) * 2008-09-03 2010-03-18 Masao Kikuchi グルコサミン誘導体の製造方法
CN101735283B (zh) * 2008-11-14 2012-07-18 徐州海吉亚生物制品有限公司 一种氨基葡萄糖盐酸盐与氨基葡萄糖硫酸钾/钠盐的共结晶技术
CN102485734A (zh) * 2010-12-06 2012-06-06 张治平 一种用于增加骨密度的化合物及其合成方法
CN106749437B (zh) * 2015-11-20 2019-09-20 广东先强药业有限公司 一种硫酸氨基葡萄糖氯化钠复盐母液的回收方法
CN110305176B (zh) * 2019-06-28 2020-10-09 山东润德生物科技有限公司 一种提高氨基葡萄糖盐酸盐热稳定性的制备方法
WO2021167957A1 (en) * 2020-02-20 2021-08-26 Dianomi Therapeutics, Inc. Inorganic coatings for the sustained release of bioactive compounds

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1056331A (en) * 1963-01-18 1967-01-25 Rotta Res Lab Process for preparing glucosamine salts
FR2504929A1 (fr) * 1981-04-30 1982-11-05 Rotta Research Lab Compose stable de sulfate de glucosamine, son procede de preparation et compositions pharmaceutiques le contenant
EP0214642A2 (en) * 1985-09-09 1987-03-18 Orion-Yhtymä Oy Fermion Mixed salts of glucosamine sulphate and a process for the preparation of the same
EP0444000A2 (en) * 1990-02-22 1991-08-28 Health Maintenance Programs, Inc. Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2101585A (en) * 1936-04-09 1937-12-07 Waterbury Buckle Company Belt buckle
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1056331A (en) * 1963-01-18 1967-01-25 Rotta Res Lab Process for preparing glucosamine salts
FR2504929A1 (fr) * 1981-04-30 1982-11-05 Rotta Research Lab Compose stable de sulfate de glucosamine, son procede de preparation et compositions pharmaceutiques le contenant
US4642340A (en) * 1981-04-30 1987-02-10 Rotta Research Laboratorium S.P.A. Stable compounds of glucosamine sulphate
EP0214642A2 (en) * 1985-09-09 1987-03-18 Orion-Yhtymä Oy Fermion Mixed salts of glucosamine sulphate and a process for the preparation of the same
EP0444000A2 (en) * 1990-02-22 1991-08-28 Health Maintenance Programs, Inc. Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture

Also Published As

Publication number Publication date
GR1003096B (el) 1999-03-22
GB2321056B (en) 2000-03-29
JP4177471B2 (ja) 2008-11-05
GR970100308A (el) 1998-04-30
FR2752423B1 (fr) 2000-03-17
GB9717546D0 (en) 1997-10-22
JPH1087683A (ja) 1998-04-07
AT408884B (de) 2002-03-25
IE970547A1 (en) 2000-10-04
FR2752423A1 (fr) 1998-02-20
CA2212129A1 (en) 1998-02-19
CA2212129C (en) 2007-11-06
NL1006790C2 (nl) 1998-12-15
ATA138197A (de) 2001-08-15
ES2131014B1 (es) 2000-02-01
GB2321056A (en) 1998-07-15
CH690719A5 (it) 2000-12-29
BE1011326A5 (fr) 1999-07-06
US5847107A (en) 1998-12-08
PT102043A (pt) 1998-02-27
NL1006790A1 (nl) 1998-02-26
GB2321056A8 (en) 2000-11-13
PT102043B (pt) 2000-01-31

Similar Documents

Publication Publication Date Title
CA2227901A1 (en) Improved cement admixture product
ES2131014A1 (es) Metodo para preparar sales mixtas de glucosamina.
TW357147B (en) Process for the preparation of a tetrazole derivative in two crystalline forms and novel crystalline form of said derivative
CA2041168A1 (en) Use of alkylcarboxylic acid dimethylamides as crystallization inhibitors
CA2225528A1 (fr) Nouveaux analogues de la camptothecine, des procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
CA2203210A1 (en) Manufacture of precipitated calcium carbonate
IE830926L (en) Crystalline benzenesulfonate salts of sultamicillin
CA2171836A1 (en) Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
CA2020858A1 (en) Water treatment agent and water treatment method for boiler
HU9400868D0 (en) Sparfloxacine salts and solutions containing same and process for producing them
KR890014435A (ko) 페녹시알킬카복실산 유도체 및 이의 제조방법
EP0138616A3 (en) Nona- and dodecapeptides for augmenting natural killer cell activity, processes for making them and pharmaceutical compositions comprising them
JPS6461422A (en) Water-soluble polymeric carcinostatic agent
KR830004220A (ko) 약리적 활성 펩티드
KR890008117A (ko) 농원예용 살균제
CA2018791A1 (en) Hair treatment composition
KR960014092A (ko) 이미노카르본산염 수용액 조성물 및 이미노카르본산염의 취급방법
EP0398230A3 (en) Antiviral, highly water soluble, stable, crystalline salts of 2',3'-dideoxyinoside monohydrate, 2',3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate
ATE187735T1 (de) Thermodynamisch stabile kristallform von 4''- deoxy-4''-epi-methylamino avermectin bia/bib benzoesauresalz und verfahren zu seiner herstellung
JPS56103198A (en) 3',4',6''-trideoxyamikacin and its preparation
JPS55102596A (en) Novel antibiotic substance, bn-183b substance, and its preparation
KR840008369A (ko) 펜엠화합물의 제조방법
JPS5538301A (en) New derivative of antibiotics fortimicin and its preparation
AU621677B2 (en) Stable aqueous solutions of primycin, pharmaceutical and cosmetic compositions containing these solutions and process for preparing same
TH31343B (th) รูปแบบใหม่ของเกลืออินทรีย์ของเอ็น เอ็น-ไดอะเซทิลซิสทีน

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990701

Kind code of ref document: A1

Effective date: 19990701

PC2A Transfer of patent
FD2A Announcement of lapse in spain

Effective date: 20171124